Nanoencapsulation of Biotics: Feasibility to Enhance Stability and Delivery for Improved Gut Health
Pharmaceutics · 11.09.2025 · 17 (9) · 1180
DOI: 10.3390/pharmaceutics17091180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 11.09.2025. Verfasst von Pedro Brivaldo Viana da Silva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Experimental Nutrition, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-220, SP, Brazil. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, National Council for Scientific and Technological Development, São Paulo Research Foundation (FAPESP).
Abstract (Originalsprache)
The human gastrointestinal tract contains a complex and diverse community of microorganisms, referred to as the gut microbiota. Due to their close proximity to human cells, these microorganisms play a crucial role in maintaining the host’s health, influencing various metabolic processes, and providing protection against potentially harmful agents and pathogens. The disruption in this microbial ecosystem, known as dysbiosis, is associated with inflammatory and metabolic diseases, as well as certain types of cancer. Strategies to modulate the microbiota toward a state of homeostasis through the use of “biotics” (probiotics, prebiotics, synbiotics, and postbiotics) have increased. However, challenges such as low stability, loss of microbial viability, and difficulties in delivery to the intestine significantly decrease the progress of their clinical and nutritional applications. Microencapsulation and nanoencapsulation technologies offer potential solutions to enhance the stability, bioavailability, and controlled release of microorganisms and/or bioactive compounds within the gastrointestinal tract. Considering these aspects, this review provides a comprehensive overview of recent advances in nanoencapsulation techniques for biotics, highlighting their mechanisms of action, potential health benefits, and applications in functional foods and targeted therapies. Furthermore, it addresses existing limitations, evaluates feasibility, and discusses the future potential of these technologies in promoting gut health and disease prevention. Further research, especially through clinical studies, is mandatory to verify the safety and effectiveness of nanoencapsulated biotics and to obtain regulatory approval.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food Science and Experimental Nutrition, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-220, SP, Brazil.
- Food Research Center (FoRC), CEPID-FAPESP (Research, Innovation and Dissemination Centers, São Paulo Research Foundation), CEPIX-USP, São Paulo 05508-080, SP, Brazil.
- Food and Nutrition Research Center (NAPAN), University of São Paulo, São Paulo 05508-220, SP, Brazil.
ORCID-Profile: Thiécla Katiane Osvaldt Rosales, João Paulo Fabi
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Council for Scientific and Technological Development
- São Paulo Research Foundation (FAPESP)
Zitieren
APA
Silva, P. B. V. D., Rosales, T. K. O., & Fabi, J. P. (2025). Nanoencapsulation of Biotics: Feasibility to Enhance Stability and Delivery for Improved Gut Health. Pharmaceutics, 17(9), 1180. https://doi.org/10.3390/pharmaceutics17091180
Vancouver
Silva PBVD, Rosales TKO, Fabi JP. Nanoencapsulation of Biotics: Feasibility to Enhance Stability and Delivery for Improved Gut Health. Pharmaceutics. 2025;17(9):1180. doi:10.3390/pharmaceutics17091180
BibTeX
@article{Silva2025,
author = {Silva, Pedro Brivaldo Viana da and Rosales, Thiécla Katiane Osvaldt and Fabi, João Paulo},
title = {Nanoencapsulation of Biotics: Feasibility to Enhance Stability and Delivery for Improved Gut Health},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {9},
pages = {1180},
doi = {10.3390/pharmaceutics17091180}
}
EUVIMED